Tilray - AI Stock Analysis

Analysis generated October 14, 2025

Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The company is among the leaders in the global cannabis market and is committed to advancing the quality of life for patients and consumers through safer, better, and more consistent pharmaceutical-grade cannabinoids. Headquartered in Canada, Tilray operates through various subsidiaries in different regions, offering a wide range of products including medical cannabis, adult-use cannabis, and hemp-based foods and wellness products.

Fundamental Analysis

Tilray's revenue for the last quarter was $210 million. This represents a decrease of 32.00% compared to the quarter before it, raising concerns about the company's ability to sustain its revenue momentum. Additionally, the revenue was down by 22.36% compared to the same quarter last year, which could indicate potential issues in market demand or competitive pressures.

On a positive note, Tilray's net income for the last quarter was $320,000. This is an increase of 99.98% compared to the quarter before, showing a significant improvement in profitability. Compared to the same quarter last year, net income increased by 99.39%, indicating consistent year-over-year growth.

EBITDA for the last quarter was $13 million. This is an increase of 100.68% compared to the previous quarter, highlighting a robust improvement in operational efficiency. Compared to the same quarter last year, the EBITDA saw an increase of 18.37%, cementing a longer-term positive growth trajectory for the company.

Technical Analysis

The current stock price of Tilray is $1.69. This represents an increase of 50.89% compared to a month ago, indicating a strong positive short-term trend. Compared to a year ago, the stock price has increased by 7.64%, suggesting a moderately positive long-term trend. Overall, the trend for Tilray's stock is bullish.

The current Simple Moving Average (SMA10) is $1.73, which is higher than the previous SMA10 of $1.72. This indicates a potential upward trend in price movement. Additionally, the Relative Strength Index (RSI) is at 69.4, which suggests a neutral to slightly overbought condition.

Alternative Data Analysis

In terms of job postings, Tilray currently has 93 open positions, up by 27% in the last couple of months. This indicates that the company is growing and looking to expand, generally a healthy sign for future business prospects. However, employee sentiment is low, with only 28% of employees having a positive outlook. The business outlook among employees has declined by 7% in the last couple of months, which is concerning.

Regarding customer acquisition, Tilray's estimated website visitors are 43,000, down by 9% in the last couple of months. This trend is worrisome as it may indicate a loss in customer interest or engagement. Tilray has 35,000 followers on their Twitter page, with no significant change in the last couple of months, showing stagnant customer engagement.

The AltIndex's AI score for Tilray is 44, which is a hold signal, indicating a balanced view of the company's current stock price based on fundamental, technical, and alternative data analyses.

Conclusion and Recommendation

In summary, Tilray presents a mixed bag of both positive and concerning signs. The company shows significant improvements in net income and EBITDA, demonstrating operational efficiency and profitability. However, the declining revenue raises concerns about market demand and competitive pressures. The stock's technical indicators suggest a bullish trend in the short term. However, alternative data such as low employee sentiment and declining website traffic present risks that could impact future performance.

Based on the given data, a cautious approach is recommended for potential investors. While there are positive aspects of Tilray's financials and technical markers, the risks highlighted in alternative data should not be overlooked. It would be prudent to monitor the company's performance closely and consider holding the stock for the time being.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.